A detailed history of Calamos Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Calamos Advisors LLC holds 965,233 shares of PFE stock, worth $25.7 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
965,233
Previous 988,915 2.39%
Holding current value
$25.7 Million
Previous $27.7 Million 0.95%
% of portfolio
0.17%
Previous 0.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$27.7 - $31.39 $655,991 - $743,377
-23,682 Reduced 2.39%
965,233 $27.9 Million
Q2 2024

Jul 25, 2024

SELL
$25.26 - $29.6 $9.08 Million - $10.6 Million
-359,419 Reduced 26.66%
988,915 $27.7 Million
Q1 2024

May 08, 2024

SELL
$25.89 - $29.73 $645,748 - $741,525
-24,942 Reduced 1.82%
1,348,334 $37.4 Million
Q4 2023

Jan 31, 2024

SELL
$26.13 - $33.94 $296,680 - $385,354
-11,354 Reduced 0.82%
1,373,276 $39.5 Million
Q3 2023

Oct 25, 2023

BUY
$32.09 - $37.51 $41,331 - $48,312
1,288 Added 0.09%
1,384,630 $45.9 Million
Q2 2023

Jul 28, 2023

BUY
$36.12 - $41.79 $23,911 - $27,664
662 Added 0.05%
1,383,342 $50.7 Million
Q1 2023

May 03, 2023

SELL
$39.39 - $51.28 $5.22 Million - $6.79 Million
-132,472 Reduced 8.74%
1,382,680 $56.4 Million
Q4 2022

Jan 25, 2023

SELL
$41.75 - $54.5 $8.8 Million - $11.5 Million
-210,709 Reduced 12.21%
1,515,152 $0
Q3 2022

Oct 24, 2022

SELL
$43.76 - $53.42 $6.02 Million - $7.35 Million
-137,558 Reduced 7.38%
1,725,861 $75.5 Million
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $6.08 Million - $7.21 Million
130,641 Added 7.54%
1,863,419 $97.7 Million
Q1 2022

May 03, 2022

BUY
$45.75 - $56.69 $8.36 Million - $10.4 Million
182,747 Added 11.79%
1,732,778 $89.7 Million
Q4 2021

Feb 01, 2022

SELL
$41.32 - $61.25 $709,009 - $1.05 Million
-17,159 Reduced 1.09%
1,550,031 $91.5 Million
Q3 2021

Oct 26, 2021

BUY
$39.25 - $50.42 $6.96 Million - $8.94 Million
177,387 Added 12.76%
1,567,190 $67.4 Million
Q2 2021

Jul 22, 2021

BUY
$35.91 - $40.68 $8.97 Million - $10.2 Million
249,928 Added 21.93%
1,389,803 $54.4 Million
Q1 2021

Apr 12, 2021

BUY
$33.49 - $37.77 $878,878 - $991,198
26,243 Added 2.36%
1,139,875 $41.3 Million
Q4 2020

Jan 27, 2021

SELL
$33.47 - $42.56 $1.21 Million - $1.54 Million
-36,154 Reduced 3.14%
1,113,632 $41 Million
Q3 2020

Oct 26, 2020

SELL
$31.75 - $37.25 $8.2 Million - $9.62 Million
-258,383 Reduced 18.35%
1,149,786 $42.2 Million
Q2 2020

Jul 27, 2020

SELL
$30.12 - $36.54 $1.82 Million - $2.21 Million
-60,408 Reduced 4.11%
1,408,169 $46 Million
Q1 2020

Apr 28, 2020

SELL
$27.03 - $38.62 $52.2 Million - $74.5 Million
-1,929,737 Reduced 56.79%
1,468,577 $47.9 Million
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $4.69 Million - $5.32 Million
142,490 Added 4.38%
3,398,314 $133 Million
Q3 2019

Oct 21, 2019

SELL
$32.49 - $42.13 $3.65 Million - $4.73 Million
-112,210 Reduced 3.33%
3,255,824 $117 Million
Q2 2019

Aug 07, 2019

BUY
$36.98 - $41.52 $17.8 Million - $20 Million
482,579 Added 16.72%
3,368,034 $146 Million
Q1 2019

Apr 12, 2019

BUY
$37.5 - $41.2 $25.7 Million - $28.2 Million
684,490 Added 31.1%
2,885,455 $123 Million
Q4 2018

Jan 24, 2019

BUY
$38.47 - $43.86 $5.21 Million - $5.94 Million
135,528 Added 6.56%
2,200,965 $96.1 Million
Q3 2018

Oct 22, 2018

SELL
$34.47 - $41.81 $1.75 Million - $2.12 Million
-50,686 Reduced 2.4%
2,065,437 $91 Million
Q2 2018

Jul 17, 2018

BUY
$32.98 - $35.16 $3.37 Million - $3.59 Million
102,245 Added 5.08%
2,116,123 $76.8 Million
Q1 2018

Apr 13, 2018

BUY
$31.91 - $37.02 $944,504 - $1.1 Million
29,599 Added 1.49%
2,013,878 $71.5 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $1.51 Million - $1.61 Million
-45,521 Reduced 2.24%
1,984,279 $71.9 Million
Q3 2017

Oct 25, 2017

BUY
$31.0 - $34.15 $861,800 - $949,370
27,800 Added 1.39%
2,029,800 $72.5 Million
Q2 2017

Aug 09, 2017

BUY
N/A
2,002,000
2,002,000 $67.2 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.